23.03.2016 • News

Bain Capital Exits IMCD

US private equity firm Bain Capital has sold its remaining 7.9% stake in Netherlands-based specialty chemicals distributor IMCD.

Bain placed 4.2 million shares, priced at €31.25 per share, with institutional investors. The transaction was led by Goldman Sachs International and Deutsche Bank.

Bain used to be IMCD’s main shareholder before the distributor launched an initial public offering (IPO) on the Amsterdam Euronext stock exchange in June 2014. Bain had already reduced its interest from 39.17% to 7.9% by the end of last year.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read